Pharmedus group – a joint name of the group of enterprises consisting of pharma-marketing and distribution company "LITfas Pharmaceuticals" and  "Norfachema Packaging" pharmaceutical packaging company

Online marketing of our products (in Lithuanian)



Our partners:

Rowatinex caps. N 50, N 100
Purpose. Kidney stones treatment


Capsules: Yellow, spherical, enteric-coated soft gelatin capsules containing a pale yellow or greenish-yellow oil.



Capsules: Each enteric-coated capsule contains -
Pinene (α + β) 31 mg, Camphene 15 mg, Cineol B.P.C. (1973) 3 mg, Fenchone 4 mg, Borneol 10 mg, Anethol U.S.P. 4 mg and Olive Oil B.P. 33 mg.



Rowatinex promotes diuresis and relaxes urinary tract spasm. thus assisting the passage of stones. The therapeutic effect of the balanced combination of terpenes reduces urinary tract inflammation stimulating renal blood flow through the kidneys and increasing the output of a less concentrated urine.
Rowatinex is indicated for the treatment of urinary tract spasm and inflammation associated with urolithiasis. Rowatinex also assists in the dissolution and expulsion of stones in the renal system
Dosage and Administration
Route of Administration: Oral.
Recommended Dosage:
Adults: Unless otherwise directed by the physician, the usual dose is 1 - 2 capsules three times daily before meals. In case of colic 2 - 3 capsules four - five times daily.
Children 6-14 years: The usual dose is 1 capsule twice daily before meals.


 Padma Qualiphar FrezyDerm Trenka Tender Corporation Rowa Alta Care Pharma Science Gilbert Laboratories Asavita Cefak Isis Pharma
© Visos teisės saugomos. 2009 UAB "LITfas".